Product approval information is indicated for adults and children with hemophilia B for: (1) On-demand treatment and control of bleeding episodes, (2) Perioperative management, (3) Routine prophylaxis to reduce the frequency of bleeding episodes.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JQV0uq
No comments:
Post a Comment